Table 2 Sociodemographic data, results of questionnaires and lung function test according to long-term use of supplementary oxygen
From: Quality of life in idiopathic pulmonary fibrosis in Latin American countries
Variables | With oxygen supplementary n = 20 | Without oxygen supplementary n = 55 | p |
|---|---|---|---|
Age, years (± SD) | 72 ± 7 | 75 ± 8 | 0.12 |
Gender, male (%) | 18 (90) | 42 (76) | 0.32 |
BMI, kg/m2 (± SD) | 26 ± 5 | 27 ± 4 | 0.49 |
Questionnaires | |||
SGRQ-I, activity (± SD) | 80 ± 22 | 66 ± 23 | 0.01 |
SGRQ-I, symptoms (± SD) | 61 ± 20 | 43 ± 20 | < 0.0001 |
SGRQ-I, impact (± SD) | 54 ± 28 | 35 ± 27 | 0.009 |
SGRQ-I, total (± SD) | 62 ± 22 | 45 ± 22 | 0.003 |
HADS (± SD) | 8 ± 6 | 10 ± 7 | 0.06 |
HADS, anxiety (± SD) | 8 ± 6 | 5 ± 4 | 0.04 |
HADS, depression (± SD) | 6 ± 5 | 5 ± 5 | 0.26 |
Torvan index (± SD) | 20 ± 5 | 16 ± 6 | 0.002 |
Lung function test | |||
FVC, predicted (± SD) | 64 ± 22 | 81 ± 19 | 0.001 |
DLCO adjusted, predicted (± SD) | 43 ± 14 | 59 ± 20 | 0.003 |
6MWT, meters (± SD) | 317 ± 168 | 398 ± 135 | 0.01 |